News

Filter

Current filters:

None

107 to 116 of 98134 results

EC approves new indication for Novartis’ Jakavi

EC approves new indication for Novartis’ Jakavi

17-03-2015

The European Commission has approved Swiss pharma giant Novartis’ Jakavi (ruxolitinib) for the treatment…

BiotechnologyEuropeIncyte CorpJakafiJakaviNovartisOncologyRegulation

Over 80% of Americans would buy generic Rx drug more often than branded product

Over 80% of Americans would buy generic Rx drug more often than branded product

17-03-2015

Americans favor generic prescription drugs over brand name products by a considerable margin, according…

GenericsMarkets & MarketingPharmaceutical sciencesPharmaceuticals policyUSA

Positive final Phase IIa safety results for Neurotrope’s Alzheimer's drug

Positive final Phase IIa safety results for Neurotrope’s Alzheimer's drug

17-03-2015

US orphan disease specialist Neurotrope saw its shares rise over 5% to $1.25 after it released secondary…

bryostatin-1NeurologicalNeurotropePharmaceuticalResearch

Pharmacyclics and Janssen Biotech’s Imbruvica trial in CLL and SLL meets primary endpoint

Pharmacyclics and Janssen Biotech’s Imbruvica trial in CLL and SLL meets primary endpoint

17-03-2015

US biopharma company Pharmacyclics and Johnson & Johnson subsidiary Janssen Biotech have announced that…

BiotechnologyImbruvicaJanssen BiotechOncologyPharmacyclicsResearchUSA

Russian government may allow parallel drug imports to the country

Russian government may allow parallel drug imports to the country

17-03-2015

The Russian government may allow parallel imports (imports of non-counterfeit product from another country…

Markets & MarketingPharmaceuticalPoliticsRussia

Lilly, GSK and Janssen join UK government's $100 million Dementia Discovery Fund

Lilly, GSK and Janssen join UK government's $100 million Dementia Discovery Fund

17-03-2015

The UK’s Health Secretary Jeremy Hunt has announced a collaborative dementia research initiative between…

Eli LillyGSKJanssenNeurologicalPharmaceuticalResearchUK

Actavis’ acquisition of Allergan cleared by Europe

Actavis’ acquisition of Allergan cleared by Europe

17-03-2015

Ireland-headquartered generics major Actavis has received clearance from the European Commission for…

ActavisAllerganEuropeMergers & AcquisitionsPharmaceutical

NantWorks and Sorrento enter second collaboration on novel anti-cancer immunotherapies

NantWorks and Sorrento enter second collaboration on novel anti-cancer immunotherapies

17-03-2015

Privately-held NantWorks and Sorrento Therapeutics have entered into a second global collaboration, this…

BiotechnologyLicensingNantworksOncologyResearchSorrento Therapeutics

Australia’s GMiA launches a Guide to Biosimilars

Australia’s GMiA launches a Guide to Biosimilars

17-03-2015

The Australian Generic Medicines Industry Association (GMiA) has today launched the GMiA Guide to Biosimilars…

AustraliaBiosimilarsGenericsMarkets & MarketingPricing

107 to 116 of 98134 results

Back to top